Jordan Johnson, Founder and Principal at Bridge Oncology and Legal Data Expert, shared on LinkedIn:
“AI is no longer a future conversation in oncology. It is a governance conversation happening now.
Cancer centers are being presented with more tools, promises, pilots, and “solutions” than most leadership teams can reasonably evaluate. The question is not whether AI will enter oncology. It already has. The question is whether we will deploy it with the clinical, operational, financial, and patient-centered discipline cancer care demands.
That is why shift matters.
A room intentionally built around oncology leaders, not vendors, creates the opportunity for the conversations that are too often avoided:
What problem are we truly solving?
What workflows are ready?
What should be declined?
Who owns accountability when an algorithm influences care, access, documentation, or resource allocation?
The best technology does not replace clinical judgment, operational architecture, or governance. It should strengthen all three.
I am looking forward to seeing the practical work that comes out of this gathering, and especially the shared whitepaper developed with the leaders in the room. Oncology does not need more AI noise. It needs disciplined deployment that protects patients, supports clinicians, and produces measurable value.
Austin | September 25–26″
Other articles about AI in Oncology on OncoDaily.